Crohn's disease with gastroduodenal involvement: Diagnostic approach

被引:14
|
作者
Ingle, Sachin B. [1 ]
Adgaonkar, Baban D. [2 ]
Jamadar, Nawab P. [3 ]
Siddiqui, Saleha [1 ]
Hinge, Chitra R. [2 ]
机构
[1] MIMSR Med Coll, Dept Pathol, Latur 4132512, Maharashtra, India
[2] MIMSR Med Coll, Dept Physiol, Latur 4132512, Maharashtra, India
[3] MIMSR Med Coll, Dept Anesthesia, Latur 4132512, Maharashtra, India
关键词
Gastrointestinal tract; Crohn's disease; Isolated gastric involvement; Perinuclear anti-neutrophil cytoplasmic antibody; Anti-Saccharomycescervisia antibody;
D O I
10.12998/wjcc.v3.i6.479
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Crohn's disease (CD) is a chronic idiopathic inflammatory disease of gastrointestinal tract characterized by segmental and transmural involvement of gastrointestinal tract. Ileocolonic and colonic/anorectal is a most common and account for 40% of cases and involvement of small intestine is about 30%. Isolated involvement of stomach is an extremely unusual presentation of the disease accounting for less than 0.07% of all gastrointestinal CD. To date there are only a few documented case reports of adults with isolated gastric CD and no reports in the pediatric population. The diagnosis is difficult to establish in such cases with atypical presentation. In the absence of any other source of disease and in the presence of nonspecific upper gastrointestinal endoscopy and histological findings, serological testing can play a vital role in the diagnosis of atypical CD. Recent studies have suggested that perinuclear anti-neutrophil cytoplasmic antibody and anti-Saccharomycescervisia antibody may be used as additional diagnostic tools. The effectiveness of infliximab in isolated gastric CD is limited to only a few case reports of adult patients and the long-term outcome is unknown.
引用
收藏
页码:479 / 483
页数:5
相关论文
共 50 条
  • [1] Crohn's disease with gastroduodenal involvement: Diagnostic approach
    Sachin B Ingle
    Baban D Adgaonkar
    Nawab P Jamadar
    Saleha Siddiqui
    Chitra R Hinge
    [J]. World Journal of Clinical Cases, 2015, 3 (06) : 479 - 483
  • [2] Ustekinumab for Crohn Disease With Severe Gastroduodenal Involvement
    Fasoulas, Konstantinos
    Stergiou, Evdoxia
    Soufleris, Konstantinos
    [J]. INFLAMMATORY BOWEL DISEASES, 2021, 27 (10) : E123 - E123
  • [3] Gastroduodenal Crohn's Disease
    Gandhi, Roopa
    Abraham, Bincy
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S360 - S360
  • [4] Gastroduodenal Crohn's disease
    Present, DH
    [J]. INFLAMMATORY BOWEL DISEASES, 2003, 9 (02) : 131 - 131
  • [5] Gastroduodenal Crohn's disease
    Fix, OK
    Soto, JA
    Andrews, CW
    Farraye, FA
    [J]. GASTROINTESTINAL ENDOSCOPY, 2004, 60 (06) : 985 - 985
  • [6] Gastroduodenal permeability in Crohn's disease
    Püspök, A
    Oberhuber, G
    Wyatt, J
    Maier-Dobersberger, T
    Hammer, J
    Pfeffel, F
    Wrba, F
    Pötzi, R
    Vogelsang, H
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1998, 28 (01) : 67 - 71
  • [7] Treatment of gastroduodenal Crohn's disease
    Mottet, C
    Juillerat, P
    Gonvers, JJ
    Michetti, P
    Burnand, B
    Vader, JP
    Felley, C
    Froehlich, F
    [J]. DIGESTION, 2005, 71 (01) : 37 - 40
  • [8] Isolated Gastroduodenal Crohn's Disease
    Sullivan, Matthew
    Hickey, Patrick
    Ahmad, Saba
    Brodsky, Jeffrey
    Shah, Hiral
    Bross, Ronald
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S439 - S439
  • [9] An Obscure Presence of Gastroduodenal Involvement in a Newly Diagnosed Ileocolonic Crohn's Disease Patient
    Miranda, Clive Jude
    Ali, Murad Hayatt
    Ayaz, Muddasir
    Soofi, Yousef
    Mahl, Thomas Christopher
    [J]. CASE REPORTS IN GASTROINTESTINAL MEDICINE, 2022, 2022
  • [10] Gastroduodenal Crohn's disease: medical management
    Tremaine, WJ
    [J]. INFLAMMATORY BOWEL DISEASES, 2003, 9 (02) : 127 - 128